Futures Rise Ahead of Today's Crucial CPI Report 📈

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. It's Tuesday, December 13th. I hope you have a great day! Let's get ready to trade! Markets 📈 US benchmarks rallied in their first trading session of the week. The S&P 500 added 1.4%, and the Dow rallied 1.5%. The Nasdaq and the small-cap Russell 2K both closed with gains of 1.2%. This morning, futures are edging higher in anticipation of November's Consumer Price Index report, which is scheduled for an 8:30 a.m. ET release. S&P 500 contracts are currently up half a point. Sponsored [How to Beat Inflation with 1 Simple Trade]( 💲 Inflation is at 40-year highs and only getting worse. But no matter what happens to the economy… This simple options trade will continue generating income month after month. And now I'm revealing exactly how it works. [If you want to "out earn" rising inflation, get a step-by-step guide to this inflation-beating trade HERE.]( Premarket Highlights 🔎 🇺🇸 Record Deficits: New data showed America's federal deficit hit a record high of $249 billion last month. 📉 Crypto Withdrawals at Binance: One of the world's largest crypto exchanges, Binance, is experiencing a spike in customer withdrawals as investor confidence continues to slide in the wake of the FTX fiasco. What to Watch Today 👀 CPI Data All eyes are on today's November CPI report. Investors are expecting a 0.5% rate increase on Wednesday, but the path forward beyond that remains uncertain. The market is hoping that cooling inflation will convince the Fed to ease off its rate hike path, so an unexpectedly hot reading could create additional volatility in today's trading session. International 🌍 Asia The Indian BSE Sensex and Hong Kong's Hang Seng Composite posted gains of 0.6% overnight. Australia's ASX 200 advanced 0.3%. Europe The German DAX is up 0.8%, while France's CAC 40 & the Euro Stoxx 600 are carrying 0.6% gains in an up day for Euro markets. Major Earnings 💰 Core & Main, Inc. [CNM] ... AM Photronics, Inc. [PLAB] ... AM Vince Holding Corp. [VNCE] ... AM Abm Industries Incorporated [ABM] ... PM Loop Media, Inc. [LPTV] ... PM Phx Minerals Inc. [PHX] ... PM Neuroone Medical Technologies Corporation [NMTC] ... PM Aspen Group Inc. [ASPU] ... PM Mind Technology, Inc. [MIND] ... PM Kaspien Holdings Inc. [KSPN] ... PM Economy 🏗 - NFIB small-business index [Nov] ... 6a - Consumer price index [Nov] ... 8:30a Running Hot 🔥 Gainers - Jiuzi Holdings [JZXN] >> +73.6% - Enthusiast Gaming [EGLX] >> +59.4% - Nova Lifestyle [NVFY] >> +38.6% Decliners - Quotient [QTNT] >> (46.9%) - Argo Blockchain [ARBK] >> (30.9%) - Ambrx Biopharma [AMAM] >> (20.2%) Moderna [MRNA] - Last Close: $165.13 An upbeat clinical data release is giving Moderna a boost today. The RNA vaccine pioneer and its research partner, Merck [MRK], announced a study of MRNA-4157/V940 in combination with Keytruda met its primary endpoint. In a Phase 2B Keynote-942 trial, the combo therapy met its efficacy target by reducing risk of recurrence or death by 44% vs Keytruda alone. Moderna and Merck plan to discuss the results with regulators, and the companies plan to launch a Phase 3 study in melanoma in 2023. They're also planning additional studies into the drug's effects on different tumor types. MRNA is the morning's top S&P 500 stock with a 5.3% gain on active premarket trading volume. My Take: Moderna is a huge stock, so it takes a lot of good news to move the needle. However, this collaboration sounds promising. Plus, this is a quality company with a dirt-cheap P/E of 5.97. ACM Research [ACMR] - Last Close: $8.72 ACM Research is gaining in the wake of a Monday morning announcement. The microchip manufacturer supplier introduced its Ultra PmaxTM Plasma-Enhanced Chemical Vapor Deposition (PECVD) tool yesterday morning. The announcement marks the firm's entrance into a new product category, and ACM said it expects to ship its first PECVD tool to a customer in China within the next few weeks. In a press release, CEO Jian Wang said the company estimates the launch will double its total addressable market. ACMR is up 26.3% in the premarket. My Take: ACMR traded fairly steady on Monday, despite this early morning announcement. However, shares rocketed higher at the closing bell, and now it's gaining in the premarket. Be careful here because we could see a sharp pullback at the opening bell. Netcapital [NCPL] - Last Close: $1.39 Strong earnings results are helping Netcapital breakout this morning. The FinTech stock reported Q2 results for its fiscal 2023 this morning, and its performance was stronger than expected. Netcapital generated earnings of $0.04 per share on $1.78 million in sales. Sales grew at a 48% rate, year over year, and Netcapital reported positive operating income compared to the year-earlier quarter. NCPL is up 126.6% on news of the strong sales growth. My Take: This is a very small stock with a market cap of only $6.42 million. Short figures weren't immediately available, but this move is unusually aggressive. Targeted market manipulation could be behind this rally, so be careful. Magenta Therapeutics [MGTA] - Last Close: $1.15 Magenta Therapeutics is pushing higher after a clinical update. The clinical-stage biotech firm reported data from its key blood cancer candidate at the American Society Of Hematology Annual Meeting on Monday. Preliminary results from an ongoing Phase 1/2 trial of the drug candidate, MGTA-117, showed notable clinical activity with no dose-limiting toxicities, Magenta also said it will release preliminary data from its MGTA-145 Sickle Cell trial in collaboration with Bluebird Bio [BLUE] later this month. The companies expect to have more extensive trial data from MGTA-145 to come available in the first half of 2023. MGTA is up 40.0% on active premarket trading volume in the wake of the press release. My Take: This press release tells us MGTA is staring down another potential catalyst, with a preliminary data release from MGTA-145 expected later in the month. If the early trial data is promising, MGTA could see another big rally. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](